Vol. 282, Issue 6, H2265-H2277, June 2002
Erythrocyte consumption of nitric oxide in presence and
absence of plasma-based hemoglobin
Nikolaos M.
Tsoukias and
Aleksander S.
Popel
Department of Biomedical Engineering and Center for
Computational Medicine and Biology, School of Medicine, Johns
Hopkins University, Baltimore, Maryland 21205
 |
ABSTRACT |
Experimental measurements have suggested
a consumption rate of nitric oxide (NO) by red blood cells (RBCs) that
is orders of magnitude smaller than that of an equivalent concentration of free hemoglobin in solution. This difference has been attributed to
external diffusion limitations in the transport of NO from the plasma
to the surface of the RBC or to resistance in the transport through the
erythrocytic membrane. A detailed mathematical model is developed to
quantify the resistance to NO transport around a single RBC and to
predict the consumption rate in the presence and absence of
extracellular hemoglobin. We provide a description for the NO
consumption rate as a function of hematocrit, RBC radius, membrane
permeability, and extracellular hemoglobin concentration. We predict a
first-order rate constant for NO consumption in blood between 7.5 × 102 and 6.5 × 103 s
1 at
a hematocrit of 45% for membrane permeability values between 0.1 and
40 cm/s. Our results suggest that the difference in NO uptake by RBCs
and free hemoglobin is smaller than previously reported and it is
hematocrit dependent.
red blood cells; diffusion; reaction; blood substitutes
 |
INTRODUCTION |
NITRIC
OXIDE (NO) is a signal transduction molecule of extreme
physiological importance. It is produced in a number of cells through
the enzymatic degradation of L-arginine by one of several isoforms of nitric oxide synthase (NOS). NO is a relatively reactive molecule with a short half-life in vivo. It can be degraded by a number
of reactions, but under physiological conditions, NO concentrations are
submicromolar, and it is the first-order reactions with superoxide and
heme-containing proteins such as hemoglobin (Hb) and guanylate cyclase
that should dominate its chemistry in vivo (3).
One of the important roles that NO plays in the body is the regulation
of vascular smooth muscle tone. NO produced in the vascular endothelial
cells can diffuse freely across cell membranes to the adjacent smooth
muscle where it activates the enzyme soluble guanylate cyclase, leading
to an increase in the intracellular cGMP concentration and to smooth
muscle relaxation. The close proximity of the red blood cells (RBC) to
the site of NO production and the fast consumption of NO by both oxy-
and deoxyHb observed in vitro (10, 16) suggest, however,
that a significant amount of NO will be scavenged by the blood. Thus it
is unclear how much of the endothelium-derived NO is able to reach the
smooth muscle where it needs to sustain physiologically significant
concentrations for the activation of soluble guanylate cyclase.
A number of experimental and theoretical studies have been performed to
investigate the diffusional spread of NO away from its site of
production (5, 21, 24, 36, 40). Theoretical studies have
recently been reviewed by Buerk (4). They represent a
first generation of models that consider only transport of free NO.
They do not account for preservation of NO-related bioactivity through
the formation of more stable intermediates such as
S-nitrosothiols. Theoretical simulations by Lancaster
(21) showed that physiological amounts of Hb (2 mM)
flowing in the lumen of a 20-µm arteriole scavenges significant
amounts of NO, leading to a dramatic reduction of the NO concentration
in the arteriolar smooth muscle. The result questioned earlier
experimental observations that free NO is the endothelium-derived
relaxing factor (12, 20, 26). Butler et al.
(5) included in their theoretical model a layer free of
RBCs next to the endothelium. They demonstrated that despite the
significant scavenging of NO by Hb, a substantial amount of NO diffuses
toward the smooth muscle; at least for vessels with diameters >160
µm that were examined. They also suggested that the reaction of NO
with the Hb "packed" in RBCs might be slower than the reaction of
NO with free Hb due to transport resistance through the membrane. Using
a detailed mathematical model, Vaughn et al. (36) also
suggested the importance of the RBC-free layer in the NO diffusion
toward the smooth muscle; however, they concluded that the uptake of NO
by RBCs has to be several orders of magnitude smaller than the uptake
by an equivalent amount of free Hb in solution for the concentration in
the smooth muscle to reach physiologically significant levels. It
became obvious that a more detailed description of the NO uptake by
RBCs must be incorporated in the modeling studies of NO diffusion.
Recently, two research groups performed experimental studies combined
with theoretical analyses to acquire a more detailed description for
the uptake of NO by RBCs. Liu et al. (22) measured the
disappearance of NO in a suspension of RBCs in a phosphate-buffered solution with the use of an NO-sensitive electrode. Small
concentrations of RBCs were utilized (three orders of magnitude less
than blood). The disappearance of NO followed a first-order reaction
rate with a half-life on the order of seconds. This corresponds to a
reaction rate constant ~650 times less than that of free Hb.
Utilizing a mathematical model for current flow around a
microelectrode, Lui et al. (22) were able to reproduce
their experimental observations. Thus they attributed the
significant reduction in the reaction rate to external diffusion
resistance in the transport of NO from the solution to the RBC
membrane. Assuming that this resistance remains the same independent of
hematocrit (Hct), they suggested a linear relationship between NO
consumption rate and Hct and extrapolated their prediction to normal Hct.
Vaughn et al. (35) used the "competition experiment,"
where RBCs in a suspension with free Hb are competing for NO generated in a homogenous phase by an NO donor, to measure the NO uptake by RBCs
at high Hct under conditions that should minimize the external
diffusion resistance. Measurement of the extracellular methemoglobin
(MetHb) concentration that is formed allows the estimation of the ratio
of the rate of uptake of NO by the RBC and by free Hb and, thus the
ratio of the reaction rate constants. Vaughn et al. (35)
noted that the external diffusion resistance should decrease with
increasing Hct due to a smaller plasma layer around each RBC.
Their experimental data, however, suggested that the reaction rate for
the RBCs plateaus for Hct >5%. They attributed this behavior to a
significant resistance in transport through the RBC membrane or
intracellular diffusion limitations, which become the rate-limiting
step of NO uptake at higher Hct. In experiments performed at higher Hct
(15.6%), changes in the NO donor or free Hb concentrations did not
alter the rate of uptake by RBCs, providing additional indications that
NO transport is not external diffusion limited, at least under these
experimental conditions. The NO consumption by the RBCs was a 1,000 times less than that of an equivalent concentration of free Hb.
In a subsequent study (34), they utilized a more detailed
model for the analysis of the competition experiment. The model takes
into consideration internal, external, and membrane diffusion
limitations. The model was fitted to the experimental data for the
estimation of membrane permeability or the intracellular reaction rate
constant. The predicted value in either case was 2,000 times smaller
than expected. Although the competition experiment could not
distinguish between the two resistances, the fact that significantly
reducing the intracellular Hb concentration did not affect the rate of
uptake suggested that it is likely the membrane permeability that
limits the NO transport. However, NO is a small and highly diffusible
molecule that has been previously thought to have a high membrane
permeability (3, 24, 30).
Recently, Huang et al. (17) proposed a mechanism to
explain such a significant resistance to NO transport in the RBC
membrane. They utilized the same competition experiment to estimate the rate of NO uptake by pretreated RBCs. The results suggested that altering the band 3 binding to cytoskeleton or altering metHb and
denatured Hb binding to the RBC membrane or cytoskeleton, significantly
alters NO uptake by the RBC. They concluded that RBC membrane- and
cytoskeleton-associated NO-inert proteins provide a significant barrier
for NO diffusion into the cell. In another experiment, changes in the
viscosity of the solution did not alter the NO uptake rate
significantly, suggesting negligible external diffusion limitation at
least under the conditions of the competition experiment, thus
providing additional indications that membrane resistance is the
limiting factor for NO uptake.
Administration of extracellular Hb-based oxygen carriers (HBOCs) holds
promise as an alternative to blood transfusion. The hypertensive
effects often seen after administration, however, are considered a
significant obstacle to the potential use of HBOCs (1, 29,
31-33, 38, 39). This phenomenon has been attributed to the
scavenging of NO by the plasma-based Hb. Plasma-based Hb should be able
to get closer to the endothelial cells in the lumen and can possibly
extravasate to the space between the endothelial cells and the smooth
muscle. In addition, the consumption of NO by a mixture containing RBCs
and free Hb would be different from that of RBC alone.
The purpose of this paper is to provide an analytic description for the
consumption of NO by the blood in the presence and absence of
plasma-based Hb and for different levels of Hct. Such a description is
needed for the development of detailed NO transport models in the
presence of Hb-based blood substitutes. In the process, we examine
previous hypotheses for the importance of the membrane and
extracellular transport resistances for the uptake of NO by the RBCs.
The theoretical predictions will be compared with previous analyses and
available experimental data.
 |
METHODS |
Model development.
A spherically symmetric model was utilized to characterize the uptake
of NO by an RBC as illustrated in Fig. 1.
An RBC is assumed spherical and is surrounded by a plasma layer. NO
diffuses through the plasma layer and the membrane of the RBC, reaching the intracellular region, where it reacts with the Hb through an
irreversible, fast, first-order reaction. Hb is present in abundance
inside the cell, and its concentration does not decrease significantly
from the reaction with NO. Thus we assume that the RBC represents an
infinite sink for NO. To characterize the NO uptake, we need to take
into consideration both external and internal resistances to mass
transfer as well as resistance for transport through the membrane.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic representation of the model. A spherical red
blood cell (RBC) is surrounded by a plasma layer with thickness that
depends on hematocrit (Hct). Concentration at the outer boundary of the
RBC is assumed constant. Simultaneous solution of the diffusion
reaction equations in all three layers yields a concentration profile.
Gradient of the concentration at the surface of the RBC is utilized to
estimate the consumption rate of nitric oxide (NO) by the RBC.
Integration of the profile yields the average NO concentration over the
plasma layer or over the entire simulation volume.
RR, RBC radius; RC,
cytoplasm radius; RP, plasma radius;
CP, concentration of outer boundary of plasma;
RP, radius of plasma layer. See text and
equations for other definitions of mathematical abbreviations.
|
|
In the analysis below, we assume no convective mixing facilitation of
NO transport in the plasma layer. The plasma layer
(Rp) has a finite thickness as determined by the
local Hct according to the equation
|
(1)
|
where RR is the effective radius of the
RBC, defined as the radius of a sphere with the same volume or surface
area as the RBC (a corresponding range of RR
values will be considered). NO can be consumed by a number of
substrates in the plasma layer, including superoxide and thiols and by
plasma-based Hb. An overall first-order rate expression is used to
model the NO consumption inside the plasma. Negligible consumption of
NO is assumed inside the membrane of RBC. A first-order rate expression
is used to model the NO consumption inside the RBC as well, where we
assume that it is dominated by the reaction with erythrocytic Hb.
Second-order reactions of NO such as the reaction with oxygen are
considered negligible. Differential steady-state mass balances in each
region then yield
|
(2)
|
|
(3)
|
|
(4)
|
where Dpl, Dm, and
Dcy are the diffusivity coefficients of NO in
plasma, membrane, and cytoplasm, respectively, and
kpl and kcy are the
first-order reaction rate constants of NO consumption in the plasma and
cytosolic regions.
Continuity of partial pressure and flux at the interfaces
provide the following boundary conditions
|
(5)
|
|
(6)
|
|
(7)
|
|
(8)
|
|
(9)
|
|
(10)
|
where CP is the concentration at the outer boundary
of the plasma layer and is assumed constant, and
FRBC is the rate of NO uptake by the RBC per
unit area. CP will be eliminated from the final
results and its value will not be required in the calculations. The
partition coefficient
was utilized to account for the increased solubility of NO in the membrane relative to the plasma and cytosol. For simplicity, we assumed same solubilities for NO in the plasma and
cytosol. Because we assumed negligible consumption of NO in the
erythrocytic membrane, the flux of NO at the inner and outer boundaries
of the membrane will be inversely proportional to the ratio of the
surface areas. The equations and boundary conditions are
nondimensionilized by introducing the following dimensionless variables
Plasma layer.
The solution of Eq. 2 gives the concentration profile of NO
in the plasma
|
(11)
|
where
P =
(
) = 1 and
R =
(1). Differentiation of the
solution at r = 1+ gives the rate of NO
uptake by the RBC per unit RBC area (FRBC)
|
(12a)
|
|
(12b)
|
|
(12c)
|
A more convenient description for FRBC
can be obtained by expressing the flux as a function of the average
concentration of NO in the plasma layer (
pl)
|
(13a)
|
|
(13b)
|
|
(13c)
|
Replacing
P with the dimensionless average
concentration estimated over the plasma layer (
pl)
in Eq. 12 utilizing Eq. 13, we get
|
(14a)
|
|
(14b)
|
|
(14c)
|
RBC membrane.
The solution of Eq. 3 utilizing Eqs. 6 and 7 provides the concentration profile in the membrane.
Differentiation of the solution at r = 1
provides the flux at the outer boundary
|
(15a)
|
|
(15b)
|
where
C =
(
) and Pm
represents the membrane permeability, which is commonly used to
describe the transport of species through a membrane.
Intracellular region.
The solution of the differential mass balance in the intracellular
region, Eq. 4 using Eqs. 7 and 10
yields
|
(16)
|
Differentiating Eq. 16 at r = 
utilizing Eq. 9, we get an expression for
FRBC
|
(17a)
|
where
|
(17b)
|
Equations 14, 15, and 17 describe the flux into the RBC as a function of concentration gradients
in the plasma, membrane, and cytoplasm. The three equations can be
combined by adding the three in-series resistances as follows
|
(18a)
|
where
|
(18b)
|
The total uptake of NO per unit RBC volume will be
|
(19)
|
and the local consumption of NO per unit blood volume
|
(20)
|
The average concentration of NO in the RBC (membrane and
intracellular) will be
|
(21a)
|
where
|
(21b)
|
|
(21c)
|
|
(21d)
|
Then the local (average) NO concentration CNO will
be
|
(22)
|
Replacing
pl in Eq. 20 gives
|
(23)
|
where kblood is the observed first-order
rate constant of NO consumption in the blood. Note that because of the
linearity of Eqs. 2-4, the calculated reaction rates
kRBC and kblood are
independent of the concentration CP. The half-life of NO in
the whole blood (t
) and
plasma (t
) will be
|
(24)
|
|
(25)
|
Note that the two definitions of NO half-life are equivalent for
very dilute RBC solutions (Hct
0) or for negligible NO concentration in the membrane and cytosol of the RBC
(g
0).
Parameter values.
Values used in calculations are presented in Table
1. RR can be
estimated such as to conserve either the volume (90-98
µm3) or the surface area (130-144 µm2)
of a human RBC (2, 11). Thus we examine a range of values for RR between 2.8 and 3.38 µm. The
Dpl was set to 3.3 × 10
5
cm2/s at 37°C based on the data from Malinski et al.
(24). Dpl at 25°C was assumed
2.6 × 10
5 cm2/s based on the
diffusivity of NO in water at 25°C. The Dcy
should be decreased compared with the plasma due to the high
concentration of Hb present. We set Dcy to half
the value of Dpl (i.e., 1.6 × 10
5 cm2/s at 37°C) based on the ratio of
the extracellular and intracellular diffusivities for O2
from experimental measurements (14, 28) and assuming a
similar dependence for NO. Malinski et al. (24) suggested
values for the diffusivity of NO in the lipophilic environment of a
membrane (Dm) of 0.3 × 10
5
cm2/s and a partition coefficient (
) of 6.5 for the
membrane-water system, based on measurements performed on a
1-octanol-water system at 37°C. Denicola et al. (9)
measured the diffusion coefficient of NO in the RBC plasma membrane
(0.4 × 10
5 cm2/s) and in liposomes
(1.3 × 10
5 cm2/s) at 20°C by
utilizing a fluorescence quenching technique. Thus, based on value of
0.4 × 10
5 cm2/s for
Dm and a membrane thickness of ~7 nm,
Eq. 15b suggests a Pm of ~40 cm/s.
This value is in agreement with the value of 93 cm/s reported by
Subczynski et al. (30). The value for
Pm utilized by Vaughn et al. (34)
to explain the competition experiment is 2,000 times smaller (0.041 cm/s).
Previous modeling studies have used a reaction rate constant for the
reaction of NO with oxyHb (koxy) of 25 and 34 µM
1 · s
1 (per heme) (22,
34, 35). Cassoly and Gibson (7) determined the
reaction rate by stopped-flow spectroscopy of 25 µM
1 · s
1 at 20°C and pH 7.0. Eich et al. (10) reported reaction rate constants in the
range of 30-50 µM
1 · s
1 and
similar reaction rates between oxy- and deoxyHb. In a recent study,
Herold et al. (16) suggested a reaction rate of 89 µM
1 · s
1 at 20°C and pH 7.0;
the reaction rate increases at higher pH. The temperature dependence of
the reaction is not known. Carlsen and Comroe (6) and
Cassoly and Gibson (7) suggested a temperature coefficient
of 1.25 and 1.4, respectively, per 10°C for the reaction of CO with
deoxyHb. If we assume a temperature coefficient of 1.4 per 10°C for
koxy and extrapolate the value proposed by
Herold et al. (16), we obtain koxy
at 25° and 37°C as high as 106 and 160 µM
1 · s
1, respectively.
Throughout the paper, extrapolation of the value of
koxy at 25° or 37°C is needed to simulate in
vitro experimental data or physiological conditions, respectively. We
utilize for the extrapolations a temperature coefficient of 1.4 and
note the temperature of extrapolation with a superscript on
koxy. The reaction rate constants of plasma
(kpl) and cytoplasm
(kcy), can be estimated from the product of
koxy with the heme concentration in the plasma (C
) and cytoplasm (C
), respectively. In addition, we add a small value (~1
s
1) to kpl to account for the
consumption of NO by other substrates present in the plasma. Such a
value is justified based on the reaction rate of NO with
O
[4,300 µM
1 · s
1 (13)] and
a concentration of O
in the plasma in the
subnanomolar range. The consumption of NO in the plasma is dominated by
the reaction with free Hb and in the absence of plasma-based Hb; small
consumption of NO occurs in the plasma layer mostly through reaction
with O
.
For the simulations below unless otherwise stated, we chose reference
parameter values of 45% for Hct, 2.8 µm for
RR, 40 cm/s for Pm,
3.30 × 10
5 cm2/s for
Dpl at 37°C, and 160 µM
1 · s
1 for
koxy at 37°C. We examine, however, the effect
of variation in the parameter values within the previously described ranges.
 |
RESULTS |
Model analysis.
The solution of model equations for the reference values of parameters
is presented in Fig. 2. The dimensionless
concentration (
) is plotted as a function of dimensionless distance
(r) from the center of the RBC. Control parameter values are
utilized and simulations are performed for two different levels of Hct:
45% (Fig. 2A) and 15% (Fig. 2B). The average
dimensionless concentration estimated over the plasma layer
(
pl) or over the total plasma and RBC volume
(
NO = CNO/CP) is
also plotted. There is a discontinuity in the NO concentration profile
at the RBC membrane due to the increased solubility of NO in the
lipophilic environment of the membrane. The thickness of the plasma
layer changes with Hct leading to changes in the NO uptake by the RBC.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
Dimensionless concentration as a function of
dimensionless distance from the center of the RBC. Model simulations
are performed for the reference parameter values and for two different
Hct levels, 45% (A) and 15% (B). Dimensionless
average plasma concentration ( pl) and the
dimensionless average concentration over the entire volume
( NO = CNO/CP) are also
presented. See text and equations for definitions of other mathematical
abbreviations.
|
|
In Fig. 3, we present the model
predictions for the observed kblood as a
function of model parameters within a wide range of parameter
variation. The effect of variation in a single parameter is explored
while keeping the others at the control values. Figure 3A
presents the dependence of kblood on the RBC
effective radius. The two estimations of RR
(based on the volume or surface area of human RBCs) are highlighted for
reference. The consumption rate of NO decreases with increasing RBC
radius. At the control value (solid circle)
kblood is 6.5 × 103
s
1. For a change in radius from 2.8 to 3.38 µm, there
is a 30% decrease in the NO consumption. Figure 3B examines
the dependence of kblood on
koxy. The control value is shown as a solid
circle. NO consumption is essentially constant for a wide range of
koxy values that include previously reported
values for koxy by Cassoly and Gibson
(7) and Vaughn et al. (34) (solid triangle),
Eich et al. (10) and Liu et al. (22) (solid
square), and Herold et al. (16) (open circle). In Fig.
3C the Pm changes over a wide range
of values that include the value proposed by Vaughn et al.
(34) (solid triangle) and the experimental estimate by
Subczynski et al. (30) (solid square). For
Pm values higher than 1 cm/s the dependence of
the consumption rate on Pm is small. NO
consumption decreases significantly when Pm
becomes <1 cm/s. At the value proposed by Vaughn et al.
(34) kblood is reduced more than 20 times compared with the control (solid circle).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 3.
Observed first-order reaction rate constant of NO
consumption in the blood (kblood) as a function
of RR (A), bimolecular reaction rate
constant of NO with free hemoglobin (Hb) (koxy)
(B), and membrane permeability (Pm)
(C). Solid circles represent the reference parameter values.
Other previously reported values for the parameters are also
highlighted for reference (see text).
|
|
Comparison with experimental data.
In Fig. 4 the model predictions are
compared with previously reported measurements of NO consumption by
RBCs. The erythrocytic NO consumption rate per RBC volume and per
average plasma concentration (kRBC) is plotted
as a function of Hct. Experimental data from a dilute suspension of rat
RBCs (Hct was more than 2,000 times less than normal) at 25°C are
presented (solid circles) (22). The extrapolation to
normal Hct proposed by Liu et al. (22) is also shown
(dashed line). Note that the data and model by Liu et al. were
presented in Ref. 22 on a per blood volume basis (Eq. 10 of Ref. 22) and have been converted in
this figure on a per RBC volume by dividing with Hct. Thus their model
predicts a constant kRBC independent of Hct.
Data from Carlsen and Comroe (6) are represented by a
solid triangle. Our theoretical predictions are also shown as a solid
line. To simulate the experimental conditions, we utilized a value for
RR of 2.44 µm to account for a smaller size of
rat RBC (volume of 60 µm3),
k
of 106 µM
1 · s
1 (based on a
koxy at 20°C of 89 µM
1 · s
1 and extrapolation to
25°C using a temperature coefficient of 1.4 per 10°C) and
Dpl of 2.6 × 10
5
cm2/s (Fig. 4). There is a close agreement between the
models as the Hct approaches zero. At physiological Hct, however, our
results differ from those of Liu et al. (22) by a factor
of 6. Our prediction for the half-life of NO in blood at 30% Hct
(5 × 109 RBCs/ml) is 0.23 ms, which is significantly
less than the estimate of Liu et al. The experimental data collected at
very low Hct cannot be used to distinguish between the two models.
Simulation using values for Pm and
koxy of 0.04 cm/s and 25 µM
1 · s
1, respectively, is also
presented. These values lead to significant underestimation of the
experimental data of Liu et al. (22) and Carlsen and
Comroe (6). For this value of Pm
the effect of Hct on kblood is minimal.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Model predictions for the rate of NO consumption per unit
RBC volume and per average plasma concentration
(kRBC) as a function of Hct. Model simulations
(solid lines) are presented for the control values for
Pm and k and
for a "low" Pm and
k (0.04 cm/s and 25 µM 1 · s 1, respectively). The
experimental data (solid circles) and the model predictions (dashed
line) of Liu et al. (22) are also presented. Simulations
for both models are performed with diffusivity of coefficient of NO in
plasma (Dpl) of 2.6 × 10 5
cm2/s and RR of 2.44 µm. Solid
triangle present data from Carlsen and Comroe (6).
|
|
Analysis of the "competition experiment."
In Fig. 5, we present results from the
"competition experiment" (35). The analysis of the
corresponding problem is presented in the APPENDIX. The
ratio of
kRBC/(k
C
) is presented as a function of Hct (Fig. 5A) or
C
(Fig. 5B).
Note that this is equivalent to the ratio of
kRBC/kHb in the studies
of Vaughn et al. (34, 35). Simulations are performed
utilizing the single cell model of Ref. 34 (see
APPENDIX) and for different scenarios of parameter values.
First, and in agreement with Ref. 34, we
utilized a "low" Pm (0.04 cm/s) and a
"low" k
(25 µM
1 · s
1). We also perform
simulations for a k
of 106 µM
1 · s
1 and a
Pm 1,000 times higher (40 cm/s). All simulations
were performed for Dpl of 2.6 × 10
5 cm2/s, RR of 3.38 µm, first-order reaction rate constant
(kd) = ln (2)/6
h
1, CNO donor of 10 µM, and
C
of 9 µM or Hct of 15.6%. The experimental
results presented as solid circles are extracted from Figs. 3 and 4 of
Ref. 35. The ratio kRBC/(k
C
) is essentially constant and independent of either Hct or
C
when the "low" Pm is
utilized. When the control value for Pm = 40 cm/s is utilized, a positive slope is observed in Fig. 5,
A and B. The model can simulate satisfactorily
the experimental data without the need for a 1,000 times reduction of
Pm when k
is
set to 106 µM
1 · s
1 instead of 25 µM
1 · s
1. Figure 5C
presents estimations for Pm utilizing the single
cell model of Ref. 34 and Eq. A8 in the
APPENDIX of this study. Parameter estimation is
performed for a wide range of values for
k
(25-175
µM
1 · s
1) and for values of the
ratio kRBC/(k
C
) in the range 0.0006-0.0024. Simulations were performed for Hct = 15%, Dpl of
2.6 × 10
5 cm2/s,
RR of 3.38 µm, C
of 9 µM, kd = ln(2)/6 h
1, and CNO donor of 10 µM. For high
k
values a wide range of
Pm values can produce ratios of
kRBC/(k
C
) that are in close agreement with the experimental measurements (34, 35). At low k
values only a small range of low Pm values are
in agreement with the experimental data. With typical values from
competition experiments at 15.6% Hct, of
kRBC/(k
C
) in the order of 0.0012 ± 0.0001 (35), and expected
k
within the range of 30-110
µM
1 · s
1, Fig. 5C
suggests acceptable values for Pm within the
range of 0.1-40 cm/s. On the basis of a ratio of 0.0012, an
empirical correlation was obtained that produces pairs of parameter
values for Pm and k
that satisfy the competition
experiment over the above ranges of variation for the two parameters
|
(26)
|
In Fig. 6 two independent
experimental observations are simulated for different values of
Pm. t
at
0.0126% Hct is simulated utilizing Eq. 25, RR
of 2.44 µm, and Dpl of 2.6 × 10
5 cm2/s. In addition, simulations of the
competition experiment (Eq. A8) are also performed in an
effort to simulate the change in
kRBC/(k
C
) after doubling the viscosity of the solution (Fig. 4 of Ref.
17). Simulations of the competition experiment are
performed for Hct of 15%, Dpl of 2.6 × 10
5 cm2/s, RR of 3.38 µm, C
of 9 µM, kd = ln (2)/6 h
1, and CNO donor of
10 µM. In the simulations at any given Pm, a
koxy value that satisfies Eq. 26 is
chosen and thus the pairs of Pm and
koxy utilized are in agreement
with a ratio of
kRBC(k
C
) of 0.0012. The results are compared with the experimental measurement (±SD) of 4.25 ± 0.2 s for t
(22) and the 15 ± 6% observed change in
kRBC after increasing the viscosity twofold
(17). The ranges of Pm values that
can reproduce these experimental observations with accuracy no worse
than twice the standard deviation of the measurement are highlighted.
Because these ranges do not overlap, there are no values for
Pm that would quantitatively explain both
experiments.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Experimental results from the competition experiment
(solid circles) reproduced from Figs. 3 and 4 of Vaughn et al.
(35). The ratio of reaction rate constants of NO
consumption by RBC and free Hb
[kRBC/(k C )]
is plotted as a function of Hct (A) and extracellular Hb
(B) concentration. Simulations are performed utilizing the
model of Vaughn et al. (34) and for three different
scenarios of parameter values. First scenario includes values for
Pm and k of
40 cm/s and 106 µM 1 · s 1,
respectively. Values for the second scenario are 40 cm/s and 25 µM 1 · s 1, respectively, and
values for the third scenario are 0.041 cm/s and 25 µM 1 · s 1. The following
parameters values were utilized in all three scenarios:
Dpl of 2.6 × 10 5
cm2/s, RR of 3.38 µm,
kd of ln (2)/6 h 1,
CNO donor of 10 µM, and C of 9 µM or Hct of 15.6%. C: Eq. A8 in the
APPENDIX is utilized to estimate Pm
for different values for k = 25-175 µM 1 · s 1 and
different ratios of
kRBC/(k C ) = 0.0006-0.0024. Same values were utilized as before for the rest
of the parameters. The parameter values for Pm
and k utilized in the three
scenarios above are also highlighted for reference.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
Two independent experimental observations are simulated
for different values of Pm.
t at 0.0126% Hct is simulated
utilizing Eq. 25 and the following parameters:
RR =2.44 µm and
Dpl = 2.6 × 10 5
cm2/s. In addition, simulations of the "competition
experiment" Eq. A8 are also performed in an effort to
simulate the change in
kRBC/(k C )
after doubling the viscosity of the solution for Hct =15%,
Dpl = 2.6 × 10 5
cm2/s, RR = 3.38 µm,
C = 9 µM, kd = ln(2)/6 h 1, and
CNO donor = 10 µM. In the simulations at any
given Pm a value for
k that satisfies Eq. 26
is chosen. Experimental measurements (±SD) for
t from Ref. 22 and
for the percent change in kRBC after increasing
the viscosity twofold from Ref. 17 are also shown.
|
|
NO consumption at physiological conditions.
In Fig. 7A, predictions for
kblood at physiological temperature
(k
) is presented as a function of
Hct. Different Pm values were utilized. For any
given Pm value, the corresponding
koxy at 25°C
k
was estimated utilizing Eq. 26. For the extrapolation of koxy at 37°C
(k
), a temperature factor of 1.4 per
10°C was used. The rest of the parameters were held at the reference
values. At 45% Hct, predictions for
k
vary between 7.5 × 102 and 6.5 × 103 s
1 when
Pm changes between 0.1 and 40 cm/s. In Fig.
7B, k
is compared with
the rate of reaction of free Hb. The ratio
HctC
k
/k
is plotted as a function of Pm for different
Hct. k
values are
shown in the secondary x-axis. For Pm
values between 0.1 and 40 cm/s, k
is 500-250 times less than the reaction with an equivalent
concentration of free Hb.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 7.
Model predictions for the observed first-order reaction
rate constant of NO in blood (37°C, 45% Hct),
k (A), and the ratio of
NO consumption by the blood and by an equivalent concentration of free
Hb, as a function of Hct and Pm (B).
For the simulations reference parameter values were utilized and
k from Eq. 26 and
extrapolation from 25° to 37°C using a temperature coefficient of
1.4 per 10°C. Predictions for the range of Pm
values that satisfy the "competition experiment" (Fig.
5C) are highlighted.
|
|
NO consumption after HBOC administration.
In Fig. 8, we investigate the effect of
Hct and plasma-based Hb concentration on the NO consumption. The
reference parameter values for RR,
koxy, and Pm are
utilized. The rate constant (ksol), for the NO
consumption if the erythrocytic Hb was uniformly distributed in the
solution (i.e., as if the cell were lysed) is also presented (estimated
as the product of koxy with Hct). In the absence
of plasma-based Hb, the consumption is a strong, nonlinear function of
Hct. As Hct goes to zero, kblood also approaches
zero, similar to ksol. In the presence of
plasma-based Hb, the consumption is practically constant independent of
Hct; kblood becomes equal to the product of
koxy and C
. For plasma-based heme concentrations of 40 µM (7.7 × 10
2 g/dl of
Hb), the total NO consumption is not much different from that in the
absence of plasma-based Hb and 45% Hct. However, at a physiologically
important plasma-based heme concentration of 3,000 µM (~5 g/dl of
Hb), consumption is increased significantly. The ratio
RHBOC of the consumption rate in the presence of
5 g/dl of plasma-based Hb over the consumption in the absence of
plasma-based Hb and normal Hct (i.e., 45% Hct) is presented on Fig.
8B as a function of koxy. Simulations
are performed for Pm values that change with
koxy according to Eq. 26 at 25°C
and 37°C. For the latter case, in addition to Eq. 26,
extrapolation of koxy values from 25°C to
37°C was utilized at any given Pm value, using
a temperature coefficient of 1.4 per 10°C. The consumption of NO in
the presence of 5 g/dl of plasma-based free-Hb is increased approximately two orders of magnitude relative to the
physiological condition (45% Hct).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of Hct and plasma-based Hb concentration on the NO
consumption. A: observed kblood as a
function of Hct in the presence and absence of plasma-based Hb
(C = 0 µM, 40 µM, and 3,000 µM). The rate
constant for the NO consumption if the erythrocytic Hb was uniformly
distributed in the solution is also presented
(ksol). B: ratio of NO consumption
rate in the presence of 5 g/dl of free Hb over the consumption in the
absence of free Hb at 45% Hct is presented as a function of
koxy. Simulations are performed for different
Pm values and at two different temperatures,
25°C and 37°C.
|
|
 |
DISCUSSION |
A simplified spherically symmetric mathematical model was utilized
to predict the NO consumption by RBCs. The results suggest that under
the reference parameter values, which include a value for the RBC
membrane permeability based on experimental measurements in lipid
bilayers, extracellular diffusion is the rate-limiting step. The plasma
layer surrounding each RBC and thus the extracellular diffusion
resistance depends on Hct. This leads to a nonlinear dependence of the
consumption rate on Hct. For human RBCs at 45% Hct, we predict a NO
consumption rate constant on a per blood volume basis of 6.5 × 103 s
1 or 0.7 µM
1 · s
1 on a per total heme
concentration basis, and a plasma half-life of 0.1 ms. These
predictions were based on the assumption of Pm equal to 40 cm/s, which is in agreement with the expected NO
permeability in the lipid bilayer of the RBC membrane.
The results presented in Fig. 3 suggest that under the control
conditions described above, the consumption of NO in the blood as
predicted by the model is sensitive to the effective radius of the RBC
but not to the intracellular reaction rate or the membrane permeability. The results suggest that the resistance to NO transport is dominated by the extracellular diffusion. Thus changes in the size
and probably the shape of the RBC may alter the NO consumption rate.
The values of koxy and Pm
have to decrease more than an order of magnitude for the resistances in
the two layers (i.e., intracellular and membrane) to have a significant
effect in the NO uptake by the RBC. At the value proposed by Vaughn et
al. (34) for Pm, however,
significant resistance is attributed to the membrane. Most importantly,
this value leads to a significant reduction (almost 20 times) of the
consumption rate.
Huxley and Kutchai (18, 19) tested the hypothesis that
extracellular diffusion is the rate-limiting step in the initial uptake
of O2 by RBCs in a stopped-flow apparatus. Their
experimental findings suggested that 82-100% of the resistance in
O2 uptake could be attributed to extracellular diffusion
limitations. Experimental studies for O2 uptake by RBCs by
Coin and Olson (8) are also consistent with a significant
diffusion boundary layer. This boundary layer is a result of
O2 depletion in the area surrounding the RBC, faster than
molecular diffusion or convective mixing can replenish it. NO has
similar diffusivity with O2, and Hb consumes it faster than
O2; thus a significant boundary layer should be present for
NO as well. Huxley and Kutchai (18) utilized the Frossling
correlation to predict a maximum value for the external diffusional
resistance of oxygen uptake by an RBC. Assuming laminar flow, no
extracellular reaction, and no interactions with neighboring RBCs
(i.e., infinite thickness of the plasma layer), the correlation provides a description for the Sherwood number Sh = kem
2RR/Dpl in the form
Sh = 2 + 0.6 Re1/2Sc1/3, where
kem is the external mass transfer coefficient,
the Reynolds number (Re) is defined as a function of the particles slip
velocity, and the Schmidt number (Sc) is defined as the ratio of
kinematic viscosity and diffusivity. Estimates show that the transport
is not significantly facilitated by convective mixing, yielding Sh = 2 (18). Thus we get an estimation for the
kem equal to
Dpl/RR. Applying
this relationship for NO and assuming that the membrane and internal
resistances are negligible compared with the external diffusion
resistance, we can get an estimation for the consumption of NO by RBCs
and an observed reaction rate in the blood
|
(27)
|
|
(28)
|
where SRBC and VRBC represent
the surface area and volume of RBC, respectively.
The model presented by Liu et al. (22) utilized these
assumptions and equivalent equations, and they found close agreement with experimental results for the uptake of NO by rat RBCs at very low
Hct (2,000 times smaller than normal). They concluded that the rate of
uptake of NO by RBC is diffusion limited. The small difference
(~25%) between their model and experimental data might be attributed
to the values chosen for Dpl or
RR. They utilized a value of
Dpl = 3,300 µm2/s based on
the experimental data of Malinski et al. (24) conducted at
37°C. This value is in close agreement with the expected diffusivity of NO in water at 37°C. Here we utilized a Dpl
of 2,600 µm2/s [the diffusivity of NO in water at
25°C, corresponding to the experiment (22)], the
external resistance is increased and resulting in a closer fit of their
experimental data (Fig. 4). Our analysis suggests that although these
assumptions may be valid for such low Hct, extrapolation of these
equations to higher Hct can lead to significant differences, i.e.,
sixfold at 30% Hct (Fig. 4). These differences originate from the
simplifying assumption that the plasma layer around the RBC has an
infinite thickness (which is not true for higher Hct), which leads to
an overestimation of the external diffusion resistance. Our model
utilizing the control parameter values suggests, in agreement with Liu
et al. (22), that the external diffusion resistance limits
the NO transport at low Hct. However, we also suggest that this
resistance decreases with increasing Hct, and becomes negligible as Hct
approaches one.
Vaughn et al. (34) suggested that
Pm is much lower than the value expected based
on the diffusivity and solubility of NO in lipid membranes. Their
competition experiment predicts a 2,000 times lower
Pm than the experimental value of Subczynski et
al. (30). Under such a condition there will be significant
resistance in the membrane even at very low Hct and the transport will
not be dominated by external diffusion limitations. Such a reduction of
Pm leads to a significant reduction of
kRBC at very low Hct, resulting in disagreement
with the experimental data of Liu et al. (22) (Fig. 4).
Analysis of the "competition experiment."
The disagreement illustrated in Fig. 4 between experimental
measurements for the rate of NO uptake by RBCs and the value for Pm proposed by Vaughn et al. (34)
motivated us to reexamine the analysis of the competition experiment.
For the analysis we utilized the single cell model (34) to
predict the ratio
kRBC/(k
C
) (see Eq. A8) in the APPENDIX. This is equivalent
to the ratio of kRBC/kHb in the
studies of Vaughn et al. (34, 35). We simulated experimental data for the ratio of
kRBC/(k
C
) from Ref. 35 rather than the metHb production from Ref.
34, because these data were easily extracted
from the figures, and according to Eq. A8, these data are
independent of the NO production rate (and thus, independent of
kd, CNO donor). The ratio kRBC/(k
C
) was experimentally determined in Ref. 35 from the ratio of
metHb formation in the presence and absence of RBC. In the process, the
NO production rate is eliminated from the fitting equation, and the
results are independent of the NO production rate. This is not the case
when the metHb concentration is measured only in a system with RBCs.
The formation of metHb and thus the parameter estimation results will
depend on the NO release rate from the NO donor. Interestingly,
utilizing a higher value for koxy, we were able
to reproduce the experimental findings without the need for a 1,000 times decrease in Pm (Fig. 5, A and
B). Most importantly, the value of 106 µM
1 · s
1 utilized in the
simulations represents a reasonable estimation for
k
based on the recent
results by Herold et al. (16) and extrapolation at 25°C.
Figure 5C suggests that accurate determination of
k
is needed for an
accurate estimation of Pm from the competition experiment. In addition, for high values of
k
, the ratio becomes insensitive to
Pm, suggesting that the rate of NO uptake is not
limited by transport through the RBC membrane. Thus, based on the
uncertainty in the value of k
, a
wide range of Pm values (0.1-40 cm/s) can
be in agreement with the experimental findings in the study by Vaughn
et al. (35). Uncertainty regarding other model parameters
such as Dpl and RR also
contributes, to a smaller degree, to the uncertainty in the estimation
of Pm.
Recently, Huang et al. (17) presented evidence for
significant resistance to NO transport in the RBC membrane utilizing the competition experiment. In these experiments, twofold increase in
buffer viscosity increased kRBC by only 15 ± 6%. Assuming that the change in viscosity did not change the
bimolecular rate constant of NO with the free Hb
(k
), this result implies significant
membrane resistance or a Pm less than 0.25 cm/s
(Fig. 6). A low Pm value is also suggested by
the significant increase in kRBC as a result of
chemical modifications that alter the band 3 binding to cytoskeleton or
metHb binding to RBC membrane. In some cases this increase was as high
as twofold. Figure 5 suggests that to increase the
kRBC and thus the ratio
kRBC/(k
C
) twofold from ~0.0012 to ~0.0024, Pm has to
be <0.2 cm/s. However, as Fig. 6 depicts a half-life of 4.2 s
measured by Liu et al. (22) for a suspension of RBCs with
Hct of 0.0126% yields a Pm greater than 0.8 cm/s. This limit for Pm depends on the
parameters values utilized in the simulations and can decrease as
Dpl increases. However, calculations indicate
that to produce Pm values less than 0.25 cm/s
one needs to utilize Dpl values beyond the
expected range of NO diffusivity in aqueous solutions. Thus it appears that no single value for Pm can satisfy all the
available experimental data.
Interestingly, if membrane- and cytoskeleton-associated proteins
provide a barrier for NO, then it is likely that they should also
provide a barrier for O2. At this point it is not clear
whether the experimental results by Huang et al. (17)
collected under nonphysiological conditions (presence of NO donor, free
Hb) are in disagreement with earlier experimental observations that
suggested the rate of O2 uptake by RBCs is significantly
limited by extracellular diffusion boundary layer (8, 18,
19). The conditions in the competition experiment may alter the
extracellular diffusion resistance. Thus the significance of membrane
resistance to NO transport observed may be overestimated relative to
the significance of the resistance under physiological conditions.
Quantitative information about the membrane resistance is needed, and
this information is not available due to mainly the uncertainty
regarding the value of koxy.
NO consumption at physiological conditions.
Previous experimental data have suggested a reaction rate of NO
with RBC 650-1,000 times smaller than the reaction with free Hb
(22, 34, 35). These data, however, were collected under nonphysiological conditions (i.e., different temperature and presence of NO donor and free Hb) and/or at lower Hct, and thus they do not
provide a direct measurement of kblood. The
theoretical model presented above was utilized for the interpretation
of these data and extrapolation to the desired conditions.
There is uncertainty in our prediction for the
kblood at physiological Hct (Fig.
7A). The uncertainty originates from uncertainty in
Pm. For Pm values between
0.1 and 40 cm/s, our predictions for kblood at
45% Hct are in the ranges between 7.5 × 10
2 and
6.5 × 10
3 s
1 or 0.08-0.7
µM
1 · s
1 on a per total heme
basis. The predicted reaction rate of NO with RBC is 250-500 times
smaller than the reaction with an equivalent concentration of free Hb
at 37°C (Fig. 7B), significantly less that the previous
estimates. The difference is mainly attributed to the nonlinear
dependence of NO consumption with Hct and the values assumed for
Pm and koxy.
NO consumption after HBOC administration.
The model predicts significant increase of the consumption rate of
NO in the presence of plasma-based Hb relative to that of the blood.
The consumption is essentially constant, independent of Hct. This can
be attributed to significant NO scavenging in the plasma layer
surrounding the RBC, when plasma-based Hb is present. At a
physiological important plasma-based Hb concentration of 5 g/dl, we
predict that the consumption of NO in the blood will be increased
approximately two orders of magnitude or ~20-fold per gram per
deciliter of Hb concentration in the plasma (Fig. 8B). The
exact value of this increase will depend on parameters such as membrane
permeability, temperature, and koxy. The
nonmonotonic dependence of the ratio RHBOC on
koxy observed in Fig. 8B is
attributed to the values for Pm and
koxy utilized in the simulations, which were chosen to agree with experimental measurements (Eq. 26). The value of Pm in the simulations
increased as koxy increased (Eq. 26).
The increase in koxy leads to an increase in NO
consumption in the presence of plasma based-Hb, whereas the increase in
Pm leads to an increase in the rate of NO uptake
by the blood in the absence of plasma-based Hb. The result is a ratio
of NO consumption in the presence and absence of plasma-based Hb that
change in a nonmonotonic fashion.
The predicted relative increase in NO consumption refers to a solution
of RBCs in the presence and absence of free Hb. When blood flows in an
arteriolar vessel, an RBC-free layer forms near the walls due to
hydrodynamic effects. Thus plasma-based Hb should be able to get closer
to the vessel wall than the RBCs. This will tend to further increase
the consumption of endothelium-derived NO in the presence of HBOCs
relative to normal blood.
Model limitations.
The model assumes spherical RBCs and neglects convective mixing
facilitation of NO transport in the plasma layer surrounding the RBC.
Both assumptions can affect the extracellular resistance and thus the
NO uptake by the RBCs. We also assumed negligible consumption of NO
inside the RBC membrane. Liu et al. (23) suggested 300 times more rapid reaction of NO with O2 inside the
hydrophobic environment of membranes. The small volume of the RBC
membrane and the third-order reaction rate of NO with O2,
however, suggest that this assumption has only a small impact on the
results of the transport calculations. In the development of the
model's equations, we also assumed steady state, based on the high
diffusivities and reaction rates and the small volume. We assumed that
Hb consumes the NO through an irreversible reaction. There is
increasing evidence, however, that Hb can preserve the NO bioactivity
through the nitrosylation of a cystein residue in the
-subunit of
the Hb molecule and later release the NO molecule probably in the form
of a S-nitrosothiol (15, 25, 27). At this point
it is not known to what extent this mechanism can result in the release
of free NO.
In conclusion, extracellular diffusion and/or resistance to the
transport through the RBC membrane limit the NO uptake by RBCs. At this
point there is uncertainty regarding the contribution of each of these
mechanisms under physiological conditions. For the estimation of NO
uptake rate by RBCs one needs to extrapolate data collected at very low
Hct or interpret data collected under nonphysiological conditions. In
either case, the value for Pm is required. Our
analysis, however, suggests that there is not a single value for
Pm that can describe all the available
experimental data. The uncertainty in the value of
Pm causes uncertainty in our prediction for
kblood under physiological conditions within a
range 7.5 × 102-6.5 × 103
s
1. Our prediction for blood at normal Hct is
250-500 times slower than for the reaction with an equivalent
concentration of free Hb. Further experimentation is needed to
delineate the magnitude of extracellular and RBC membrane resistance to
NO transport and determine accurately the rate of NO consumption in the
blood at physiological Hct.
 |
APPENDIX |
Competition experiment.
For the analysis of the competition experiment, we use the "single
cell" model presented by Vaughn et al. (34). It differs from the one presented earlier by the addition of a production rate in
the plasma equation and in the condition at the outer boundary of the
plasma layer. Thus Eqs. 2 and 5 are replaced by
|
(A1)
|
|
(A2)
|
Here S is the production rate of NO per unit plasma
volume, which is assumed constant for a pseudo steady-state
approximation and equal to
2kdCNO donor/(1
Hct), where
kd is a first-order reaction rate constant and
CNO donor is the concentration of NO donor computed based
on the total volume of solution. Vaughn et al. (34) have
not presented the solution explicitly; for the sake of convenience, we
present the solution here using notations introduced above in the body
of the paper.
Making the substitution
(r) = C(r)
S/kpl, the solution of Eq. A1 using the Eqs. A2 and Eq. 6 will be
|
(A3a)
|
with
|
(A3b)
|
|
(A3c)
|
Differentiating Eq. A3 at r = 1+, we get the flux at the RBC boundary under the
conditions of the competition experiment
|
(A4)
|
Similarly, combining Eq. A4 with Eqs. 15 and 17 yields
|
(A5)
|
The average NO concentration in the plasma will be
|
(A6)
|
Substitution of Eq. A6 in Eq. A5 yields
|
(A7)
|
Then the ratio of the reaction rate constants for NO consumption
by the RBC and by the extracellular Hb will be
|
(A8)
|
Taking the limit of Eq. A8 for very small
Pm, we obtain
|
(A9)
|
 |
ACKNOWLEDGEMENTS |
This project was supported by the National Institutes of Health
Grant HL-18292 and the Center for Advanced Transfusion Practices and
Blood Research.
 |
FOOTNOTES |
Address for reprint requests and other correspondence: N. Tsoukias, Dept. of Biomedical Engineering, Johns Hopkins Univ. School of Medicine, 613 Traylor Bldg., 720 Rutland Ave., Baltimore, MD 21205 (E-mail: tsoukias{at}bme.jhu.edu).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published February 28, 2002;10.1152/ajpheart.01080.2001
Received 10 December 2001; accepted in final form 22 February 2002.
 |
REFERENCES |
1.
Alayash, AI.
Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?
Nat Biotechnol
17:
545-549,
1999[Web of Science][Medline].
2.
Altman, PL,
and
Dittmer DS.
Respiration and Circulation. Bethesda, MD: Fed Am Soc Exp Biol, 1971.
3.
Beckman, JS,
and
Koppenol WH.
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.
Am J Physiol Cell Physiol
271:
C1424-C1437,
1996[Abstract/Free Full Text].
4.
Buerk, DG.
Can we model nitric oxide biotransport? A survey of mathematical models for a simple diatomic molecule with surprisingly complex biological activities.
Annu Rev Biomed Eng
3:
109-143,
2001[Web of Science][Medline].
5.
Butler, AR,
Megson IL,
and
Wright PG.
Diffusion of nitric oxide and scavenging by blood in the vasculature.
Biochim Biophys Acta
1425:
168-176,
1998.
6.
Carlsen, E,
and
Comroe JH.
The rate of uptake of carbon monoxide and of nitric oxide by normal human erythrocytes and experimentally produced spherocytes.
J Gen Physiol
42:
83-107,
1958[Abstract/Free Full Text].
7.
Cassoly, R,
and
Gibson Q.
Conformation, co-operativity and ligand binding in human hemoglobin.
J Mol Biol
91:
301-313,
1975[Web of Science][Medline].
8.
Coin, JT,
and
Olson JS.
The rate of oxygen uptake by human red blood cells.
J Biol Chem
254:
1178-1190,
1979[Abstract/Free Full Text].
9.
Denicola, A,
Souza JM,
Radi R,
and
Lissi E.
Nitric oxide diffusion in membranes determined by fluorescence quenching.
Arch Biochem Biophys
328:
208-212,
1996.
10.
Eich, RF,
Li T,
Lemon DD,
Doherty DH,
Curry SR,
Aitken JF,
Mathews AJ,
Johnson KA,
Smith RD,
Phillips GN, Jr,
and
Olson JS.
Mechanism of NO-induced oxidation of myoglobin and hemoglobin.
Biochemistry
35:
6976-6983,
1996[Medline].
11.
Fung, YC.
Biomechanics. Mechanical Properties of Living Tissues. New York: Springer-Verlag, 1993.
12.
Furchgott, RF,
and
Zawadzki JV.
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.
Nature
288:
373-376,
1980[Medline].
13.
Goldstein, S,
and
Czapski G.
The reaction of NO with O2- and HO2: a pulse radiolysis study.
Free Radic Biol Med
19:
505-510,
1995[Web of Science][Medline].
14.
Goldstick, TK,
Ciuryla VT,
and
Zuckerman L.
Diffusion of oxygen in plasma and blood.
Adv Exp Med Biol
75:
183-190,
1976[Medline].
15.
Gow, AJ,
Luchsinger BP,
Pawloski JR,
Singel DJ,
and
Stamler JS.
The oxyhemoglobin reaction of nitric oxide.
Proc Natl Acad Sci USA
96:
9027-9032,
1999[Abstract/Free Full Text].
16.
Herold, S,
Exner M,
and
Nauser T.
Kinetic and mechanistic studies of the NO(*)-mediated oxidation of oxymyoglobin and oxyhemoglobin.
Biochemistry
40:
3385-3395,
2001[Medline].
17.
Huang, KT,
Han TH,
Hyduke DR,
Vaughn MW,
Van Herle H,
Hein TW,
Zhang C,
Kuo L,
and
Liao JC.
Modulation of nitric oxide bioavailability by erythrocytes.
Proc Natl Acad Sci USA
98:
11771-11716,
2001[Abstract/Free Full Text].
18.
Huxley, VH,
and
Kutchai H.
Effect of diffusion boundary layers on the initial uptake of O2 by red cells. Theory versus experiment.
Microvasc Res
26:
89-107,
1983[Web of Science][Medline].
19.
Huxley, VH,
and
Kutchai H.
The effect of the red cell membrane and a diffusion boundary layer on the rate of oxygen uptake by human erythrocytes.
J Physiol
316:
75-83,
1981[Abstract/Free Full Text].
20.
Ignarro, LJ,
Buga GM,
Wood KS,
Byrns RE,
and
Chaudhuri G.
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Proc Natl Acad Sci USA
84:
9265-9269,
1987[Abstract/Free Full Text].
21.
Lancaster, JR, Jr.
Simulation of the diffusion and reaction of endogenously produced nitric oxide.
Proc Natl Acad Sci USA
91:
8137-8141,
1994[Abstract/Free Full Text].
22.
Liu, X,
Miller MJ,
Joshi MS,
Sadowska-Krowicka H,
Clark DA,
and
Lancaster JR, Jr.
Diffusion-limited reaction of free nitric oxide with erythrocytes.
J Biol Chem
273:
18709-18713,
1998[Abstract/Free Full Text].
23.
Liu, X,
Miller MJ,
Joshi MS,
Thomas DD,
and
Lancaster JR, Jr.
Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes.
Proc Natl Acad Sci USA
95:
2175-2179,
1998[Abstract/Free Full Text].
24.
Malinski, T,
Taha Z,
Grunfeld S,
Patton S,
Kapturczak M,
and
Tomboulian P.
Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors.
Biochem Biophys Res Commun
193:
1076-1082,
1993[Web of Science][Medline].
25.
McMahon, TJ,
Stone AE,
Bonaventura J,
Singel DJ,
and
Stamler JS.
Functional coupling of oxygen binding and vasoactivity in S-nitrosohemoglobin.
J Biol Chem
275:
16738-16745,
2000[Abstract/Free Full Text].
26.
Palmer, RM,
Ferrige AG,
and
Moncada S.
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Nature
327:
524-526,
1987[Medline].
27.
Pawloski, JR,
Hess DT,
and
Stamler JS.
Export by red blood cells of nitric oxide bioactivity.
Nature
409:
622-626,
2001[Medline].
28.
Spaan, JA,
Kreuzer F,
and
van Wely FK.
Diffusion coefficients of oxygen and hemoglobin as obtained simultaneously from photometric determination of the oxygenation of layers of hemoglobin solutions.
Pflügers Arch
384:
241-251,
1980[Web of Science][Medline].
29.
Stowell, CP,
Levin J,
Spiess BD,
and
Winslow RM.
Progress in the development of RBC substitutes.
Transfusion
41:
287-299,
2001[Web of Science][Medline].
30.
Subczynski, WK,
Lomnicka M,
and
Hyde JS.
Permeability of nitric oxide through lipid bilayer membranes.
Free Radic Res
24:
343-349,
1996[Web of Science][Medline].
31.
Ulatowski, JA,
Asano Y,
Koehler RC,
Traystman RJ,
and
Bucci E.
Sustained endothelial dependent dilation in pial arterioles after crosslinked hemoglobin transfusion.
Artif Cells Blood Substit Immobil Biotechnol
25:
115-120,
1997[Web of Science][Medline].
32.
Ulatowski, JA,
Koehler RC,
Nishikawa T,
Traystman RJ,
Razynska A,
Kwansa H,
Urbaitis B,
and
Bucci E.
Role of nitric oxide scavenging in peripheral vasoconstrictor response to beta beta cross-linked hemoglobin.
Artif Cells Blood Substit Immobil Biotechnol
23:
263-269,
1995[Web of Science][Medline].
33.
Ulatowski, JA,
Nishikawa T,
Matheson-Urbaitis B,
Bucci E,
Traystman RJ,
and
Koehler RC.
Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition.
Crit Care Med
24:
558-565,
1996[Web of Science][Medline].
34.
Vaughn, MW,
Huang K,
Kuo L,
and
Liao JC.
Erythrocyte consumption of nitric oxide: competition experiment and model analysis.
Nitric Oxide
5:
18-31,
2001[Web of Science][Medline].
35.
Vaughn, MW,
Huang KT,
Kuo L,
and
Liao JC.
Erythrocytes possess an intrinsic barrier to nitric oxide consumption.
J Biol Chem
275:
2342-2348,
2000[Abstract/Free Full Text].
36.
Vaughn, MW,
Kuo L,
and
Liao JC.
Effective diffusion distance of nitric oxide in the microcirculation.
Am J Physiol Heart Circ Physiol
274:
H1705-H1714,
1998[Abstract/Free Full Text].
37.
Vaughn, MW,
Kuo L,
and
Liao JC.
Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model.
Am J Physiol Heart Circ Physiol
274:
H2163-H2176,
1998[Abstract/Free Full Text].
38.
Winslow, RM.

-Crosslinked hemoglobin: was failure predicted by preclinical testing?
Vox Sang
79:
1-20,
2000[Web of Science][Medline].
39.
Winslow, RM.
Blood substitutes: refocusing an elusive goal.
Br J Haematol
111:
387-396,
2000[Web of Science][Medline].
40.
Wood, J,
and
Garthwaite J.
Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties.
Neuropharmacology
33:
1235-1244,
1994[Web of Science][Medline].
Am J Physiol Heart Circ Physiol 282(6):H2265-H2277
0363-6135/02 $5.00
Copyright © 2002 the American Physiological Society